Faced with this apoptotic activity of CytC and the limitations of using this protein, [31] intended to deliver this molecule with the prohibitin-targeted nanoparticle system (PTNP) to develop an effective and safe anti-obesity therapy. Here, PHB1 is linked to obesity disorder.